Annual results for Ramsay Santé as of June 2025 show a 4.7% revenue growth to €5.2bn, with EBITDA up 1.7% to €621m. Despite reduced public funding, efforts in cost control and activity growth supported growth. The Group continues its mission to expand access and elevate care across Europe, serving 13 million patients annually.

Key financial figures include a 4.7% revenue growth to €5.2bn, EBITDA up 1.7% to €621m, and a net loss of €54m. Operating profit increased by 7.8%, and debt leverage ratio improved to 4.7x. The Group’s mission-driven strategy aims to deliver tangible wins through sustainable growth and enhanced care delivery.

Ramsay Santé’s annual results highlight revenue growth in France by 5.9%, driven by acquisitions and new facilities. French tariffs saw an increase of 2.2%, offsetting government curtailed grants. The Group’s EBITDA increased by 1.7%, with a focus on cost control and efficiency actions to counter inflation and funding challenges.

The Group’s cash flow from operating activities increased by €106.9m, reflecting improved working capital. Net financial debt increased to €3,647.5m, with restated net leverage at 4.7x. Ramsay Santé’s refinancing and repricing of senior debt facilities support its long-term financing framework and strategic initiatives.

Ramsay Santé’s CEO, Pascal Roché, emphasizes the Group’s commitment to delivering integrated care services aligned with its ‘Yes We Care 2025’ strategy. Despite funding challenges, operating profitability was maintained through cost management. The Board decided not to propose a dividend payment for 2025, reflecting a focus on financial stability and growth.

Read more at GlobeNewswire: annual results at the end of June 2025